Trial NCT05073484

View at ClinicalTrials.gov 
Org. Study IDs: BAT-6021-002-CR

Last trial update was posted on 2023-10-11

MeSH Interventions

Antibodies Immunoglobulins

MeSH Conditions

Neoplasms

Other Conditions

Advanced Solid Tumor

Stopping Reasons

Based on the disclosed global research data on the same target drugs, the company has carefully considered and decided to terminate the project to optimize the existing research pipeline.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID